By Research Area
Hot products 
-
Mouse Anti-CCND2 Recombinant Antibody (DCS-3) (CBMAB-G1318-LY)
-
Mouse Anti-EIF4G1 Recombinant Antibody (2A9) (CBMAB-A2544-LY)
-
Mouse Anti-ARIH1 Recombinant Antibody (C-7) (CBMAB-A3563-YC)
-
Mouse Anti-APCS Recombinant Antibody (CBYC-A663) (CBMAB-A3054-YC)
-
Mouse Anti-BBS2 Recombinant Antibody (CBYY-0253) (CBMAB-0254-YY)
-
Mouse Anti-ACTG1 Recombinant Antibody (V2-179597) (CBMAB-A0916-YC)
-
Mouse Anti-A2M Recombinant Antibody (V2-178822) (CBMAB-A0036-YC)
-
Rabbit Anti-ABL1 (Phosphorylated Y185) Recombinant Antibody (V2-443434) (PTM-CBMAB-0001YC)
-
Mouse Anti-ARID3A Antibody (A4) (CBMAB-0128-YC)
-
Mouse Anti-APP Recombinant Antibody (DE2B4) (CBMAB-1122-CN)
-
Rabbit Anti-ALOX5AP Recombinant Antibody (CBXF-1219) (CBMAB-F0750-CQ)
-
Rabbit Anti-CBL Recombinant Antibody (D4E10) (CBMAB-CP0149-LY)
-
Mouse Anti-APOE Recombinant Antibody (A1) (CBMAB-0078CQ)
-
Mouse Anti-ATM Recombinant Antibody (2C1) (CBMAB-A3970-YC)
-
Mouse Anti-BPGM Recombinant Antibody (CBYY-1806) (CBMAB-2155-YY)
-
Mouse Anti-ELAVL4 Recombinant Antibody (6B9) (CBMAB-1132-YC)
-
Mouse Anti-BLK Recombinant Antibody (CBYY-0618) (CBMAB-0621-YY)
-
Mouse Anti-DDC Recombinant Antibody (8E8) (CBMAB-0992-YC)
-
Mouse Anti-Acetyl-α-Tubulin (Lys40) Recombinant Antibody (V2-623485) (CBMAB-CP2897-LY)
-
Mouse Anti-CHRNA9 Recombinant Antibody (8E4) (CBMAB-C9161-LY)
Post-Translational Modification (PTM) Research
While the central dogma delineates the canonical pathway of genetic information flow, the functional maturation of the proteome extends significantly beyond initial protein synthesis. To achieve biological activity, nascent polypeptide chains frequently undergo a sophisticated suite of covalent modifications, collectively termed Post-Translational Modifications (PTMs). This process represents a fundamental mechanism for amplifying the functional repertoire of the proteome, far surpassing the complexity encoded by the genome itself. Consequently, a single genetic locus can ultimately yield a multiplicity of protein isoforms, each perhaps possessing a unique physiological role.
The scope of these modifications is extensive, playing a pivotal role in virtually all aspects of cellular regulation. PTMs encompass a diverse array of chemical alterations to proteins. These modifications range from the addition of small functional groups, including phosphate (phosphorylation), methyl (methylation), and acetyl groups (acetylation), to the conjugation of larger macromolecules, such as glycosylation and ubiquitination. Such changes can profoundly modulate a protein's physicochemical properties, thereby influencing its conformation, subcellular localization, catalytic activity, and participation in molecular interaction networks. Phosphorylation, for instance, is a ubiquitous regulatory switch. In contrast, the ligation of ubiquitin chains often earmarks a protein for proteasomal degradation, thus controlling its cellular half-life. It is increasingly clear that the precise and dynamic regulation of PTMs is indispensable for the fidelity of core processes like signal transduction, DNA repair, and the orchestration of gene expression.
Understanding PTMs is critical for unraveling complex diseases, including cancer and neurodegenerative disorders, where these pathways are often dysregulated. To facilitate investigations into these complex regulatory networks, Creative Biolabs provides a comprehensive portfolio of antibody reagents meticulously developed for PTM-centric research. These reagents are rigorously validated to ensure high specificity and performance across a spectrum of standard immunological applications, including Western Blot, ELISA, immunofluorescence, chromatin immunoprecipitation (ChIP), and flow cytometry. Our objective is to furnish the scientific community with robust tools that empower deeper exploration into the fundamental roles of post-translational modifications in health and disease.
Loading...
Compare
